Cargando…

Vitamin K in Chronic Kidney Disease

Vitamin K is a composite term referring to a group of fat-soluble vitamins that function as a cofactor for the enzyme γ-glutamyl carboxylase (GGCX), which activates a number of vitamin K-dependent proteins (VKDPs) involved in haemostasis and vascular and bone health. Accumulating evidence demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cozzolino, Mario, Mangano, Michela, Galassi, Andrea, Ciceri, Paola, Messa, Piergiorgio, Nigwekar, Sagar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356438/ https://www.ncbi.nlm.nih.gov/pubmed/30646590 http://dx.doi.org/10.3390/nu11010168

Ejemplares similares

Cardiovascular disease in dialysis patients
por: Cozzolino, Mario, et al.
Publicado: (2018)

SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease
por: Podestà, Manuel Alfredo, et al.
Publicado: (2023)

Current Therapy in CKD Patients Can Affect Vitamin K Status
por: Cozzolino, Mario, et al.
Publicado: (2020)

Early aging and premature vascular aging in chronic kidney disease
por: Tanriover, Cem, et al.
Publicado: (2023)

The Key Role of Phosphate on Vascular Calcification
por: Cozzolino, Mario, et al.
Publicado: (2019)

Dietary Habits, Vitamin and Mineral Supplements in Patients with Chronic Kidney Disease (CKD)
por: Messa, Piergiorgio
Publicado: (2020)

Calciphylaxis after kidney transplantation: a rare but life-threatening disorder
por: Podestà, Manuel Alfredo, et al.
Publicado: (2021)

Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study
por: Ciceri, Paola, et al.
Publicado: (2020)

Do we need new phosphate binders in dialysis?
por: Cozzolino, Mario, et al.
Publicado: (2020)

Phosphate binders in dialysis: better satisfied than sorry
por: Cozzolino, Mario, et al.
Publicado: (2021)

Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease
por: Ciceri, Paola, et al.
Publicado: (2022)

An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease
por: Fabrizi, Fabrizio, et al.
Publicado: (2021)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
por: Cozzolino, Mario, et al.
Publicado: (2017)

Effects of a medium cut-off (Theranova(®)) dialyser on haemodialysis patients: a prospective, cross-over study
por: Cozzolino, Mario, et al.
Publicado: (2019)

Vitamin D receptor activation: cardiovascular and renal implications
por: Nigwekar, Sagar U, et al.
Publicado: (2013)

Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review
por: Fishbane, Steven N., et al.
Publicado: (2021)

Efficacy and Safety of COVID-19 Vaccine in Patients on Renal Replacement Therapy
por: Frittoli, Michela, et al.
Publicado: (2022)

Vitamin K Status in Chronic Kidney Disease
por: McCabe, Kristin M., et al.
Publicado: (2013)

The Vitamin K Metabolome in Chronic Kidney Disease
por: Turner, Mandy E., et al.
Publicado: (2018)

Which Vitamin D in CKD-MBD? The Time of Burning Questions
por: Galassi, Andrea, et al.
Publicado: (2013)

Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation
por: Bover, Jordi, et al.
Publicado: (2011)

1,25-dihydroxyvitamin D as Predictor of Renal Worsening Function in Chronic Kidney Disease. Results From the PASCaL-1,25D Study
por: Galassi, Andrea, et al.
Publicado: (2022)

Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19
por: Galassi, Andrea, et al.
Publicado: (2022)

Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients
por: Cunningham, John, et al.
Publicado: (2012)

COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis?
por: Cozzolino, Mario, et al.
Publicado: (2021)

Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins
por: Ciceri, Paola, et al.
Publicado: (2021)

Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress
por: Dozio, Elena, et al.
Publicado: (2021)

The emerging role of iron in heart failure and vascular calcification in CKD
por: Ciceri, Paola, et al.
Publicado: (2020)

Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice
por: Alfieri, Carlo, et al.
Publicado: (2019)

Vitamin K and Kidney Transplantation
por: Fusaro, Maria, et al.
Publicado: (2020)

Nutritional Vitamin D in Renal Transplant Patients: Speculations and Reality
por: Messa, Piergiorgio, et al.
Publicado: (2017)

Clinical Impact of Hypercalcemia in Kidney Transplant
por: Messa, Piergiorgio, et al.
Publicado: (2011)

A roadmap to parathyroidectomy for kidney transplant candidates
por: Cianciolo, Giuseppe, et al.
Publicado: (2022)

Dabigatran overload in acute kidney injury: haemodialysis or idarucizumab? A case report and proposal for a decisional algorithm
por: Galassi, Andrea, et al.
Publicado: (2020)

Extended-release calcifediol in stage 3–4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D
por: Cozzolino, Mario, et al.
Publicado: (2021)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2021)

Frailty phenotype and multi-domain impairments in older patients with chronic kidney disease
por: Vettoretti, Simone, et al.
Publicado: (2020)

Therapeutic Effect of Iron Citrate in Blocking Calcium Deposition in High Pi-Calcified VSMC: Role of Autophagy and Apoptosis
por: Ciceri, Paola, et al.
Publicado: (2019)

Vitamin K Dependent Proteins in Kidney Disease
por: Silaghi, Ciprian N., et al.
Publicado: (2019)

The ideal marker for measuring GFR: what are we looking for?
por: Claudio, Maioli, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_41o1kop4s3orsksi3fannil044